Physician profile
Phuc Vo
NPI 1023080892
$3,869.44
in general payments reported to CMS, 2019-2025
24 companies · $1,531 in 2025
The $1,531 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $279 · 2020: $242 · 2021: $400 · 2022: $468 · 2023: $473 · 2024: $477 · 2025: $1,531.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,958 · Travel and Lodging: $386 · Education: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,958.08 |
| Travel and Lodging | $385.88 |
| Education | $137.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coastal Medical Technologies LLC | $1,109.82 | 2023-2025 | |
| Zimmer Biomet Holdings, INC. | $859.54 | 2019-2025 | Persona, Comprehensive Shoulder System, Tapestry |
| Mvp Orthopedics INC | $566.16 | 2021-2023 | |
| Horizon Therapeutics Plc | $355.58 | 2019-2022 | |
| Medical Device Business Services, INC. | $219.93 | 2025 | Stratafix |
| Abbvie INC. | $140.16 | 2021-2025 | Dalvance |
| Ethicon US, LLC | $105.62 | 2024-2025 | Vistaseal, Stratafix, Dermabond Prineo |
| Ferring Pharmaceuticals INC. | $55.82 | 2020-2022 | |
| Linvatec Corporation | $53.79 | 2019 | |
| Smith+Nephew, INC. | $50.76 | 2019-2023 | Journey II |
| Bone Support INC. | $42.86 | 2022 | |
| Illuminoss Medical, INC. | $42.11 | 2022 | |
| Fidia Pharma USA INC. | $39.56 | 2020-2022 | |
| Stryker Corporation | $34.88 | 2023 | Aequalis Perform Reversed, Blueprint Patient Specific Instrumentation |
| Amgen INC. | $33.82 | 2019-2024 | Prolia, Evenity |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $26.43 | 2022 | |
| Sanofi-Aventis U.S. LLC | $22.74 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $19.74 | 2023 | Iovera, Zilretta, Exparel |
| Catalyst Orthoscience | $18.49 | 2021 | |
| Vericel Corporation | $18.36 | 2023 | Maci |
| Convatec INC. | $17.69 | 2023 | |
| Kci USA, INC. | $13.18 | 2022 | |
| Heron Therapeutics, INC. | $12.75 | 2023 | Zynrelef |
| Musculoskeletal Transplant Foundation INC. | $9.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phuc Vo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.